CLINICAL_TRIALS
trial_result
· 2024-10-31
Clinical Trial Update: Safety and Tolerability Study of MSC Exosome Ointment [Phase 1]
Summary
Phase 1 safety and tolerability study of MSC-derived exosome ointment for psoriasis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Paracrine Therapeutics Dermatology Pte. Ltd. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2024-10-31